High-dose Vitamin D Supplementation and Exercise for Cancer-treatment-induced Bone Loss in Breast Cancer Patients on Aromatase Inhibitors: a Phase Ii Rct
Year: 2019
Type: other
Abstract: Tablet Based Expanded Pain Assessment Reveals Severe Flares and End of Dose Pain at HomeBackground: Cancer pain prevalence is high (52%-77%) and includes pain flares and end of dose failure. Successful pain management requires comprehensive systematic assessment. Methods: An Expanded Pain Assessment (EPA) was developed into an electronic care planning system (CPS), combining the Brief Pain Inventory with drill down questions about breakthrough pain (BTP). 52 patients with advanced cancer at three sites completed the tablet-based EPA prior to the clinician visit. Results were presented on a dashboard, and the provider and patient collaboratively established a pain care plan. Effectiveness of pain management planning was measured with the Pain Care Quality Survey (PCQS).Results: Patients were 63% (n=32) female with mean age of 56 (range 20-93). Mean pain scores were 3.13 (scale 1-10); 88% had a pain flare in the last seven days with mean severity of 8.23; 74% of flares lasted > 30 minutes; 80% had end of dose pain. Participants reported incident pain associated with certain activity (70%) as well as insidious pain not associated with activity (70%). 52 patients selected 132 pain descriptors: burning (11), achy (23), stabbing (20), pins and needles (12), cramping (11) radiating (14), intermittent (20), and continuous (21). PCQS mean score was 10.80 (scale 2-12), SD-1.18. Mean satisfaction with tablet-based EPA use was 3.25 (scale 0-4), SD 0.58Conclusions: Comprehensive pain assessment with an EPA revealed important details that were incorporated into the management plan. Since patients were experiencing severe flares and end of dose pain at home, strategies to engage patients between visits should be evaluated.
Author: Luke Peppone
Language: English
Topic: Vitamin D Research Studies
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4213154075